Tilray Brands, Inc. Increase (Decrease) in Inventories
Tilray Brands, Inc. (TLRY) reported Increase (Decrease) in Inventories of $13.44 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-28
- Tilray Brands, Inc. increase (decrease) in inventories for the quarter ending 2026-05-31 was -$7.98M, a 199.97% decline year-over-year.
- Tilray Brands, Inc. increase (decrease) in inventories for the quarter ending 2026-02-28 was $9.11M.
- Tilray Brands, Inc. increase (decrease) in inventories for the quarter ending 2025-11-30 was $411.00K.
- Tilray Brands, Inc. increase (decrease) in inventories for the quarter ending 2025-08-31 was $11.90M, a 3.86% decline year-over-year.
- Tilray Brands, Inc. increase (decrease) in inventories for fiscal 2026 was $13.44M, a 0.90% decline from fiscal 2025.
- Tilray Brands, Inc. increase (decrease) in inventories for fiscal 2025 was $13.56M, a 12.95% decline from fiscal 2024.
- Tilray Brands, Inc. increase (decrease) in inventories for fiscal 2024 was $15.58M, a 20.44% increase from fiscal 2023.
- Tilray Brands, Inc. increase (decrease) in inventories for fiscal 2023 was $12.93M, a 71.73% decline from fiscal 2022.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | -$7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $1.12M derived: sum of 2 quarters · filed 2026-07-28 | $1.53M derived: sum of 3 quarters · filed 2026-07-28 | $13.44M 10-K · filed 2026-07-28 | |||
| 2026-02-28 | $9.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $9.52M derived: sum of 2 quarters · filed 2026-04-01 | $21.42M 10-Q · filed 2026-04-01 | $29.41M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-11-30 | $411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $12.32M 10-Q · filed 2026-01-08 | $20.30M derived: sum of 3 quarters · filed 2026-07-28 | $17.75M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-08-31 | $11.90M 10-Q · filed 2025-10-09 | $19.89M derived: sum of 2 quarters · filed 2026-07-28 | $17.34M derived: sum of 3 quarters · filed 2026-07-28 | $13.08M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-05-31 | $7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $5.43M derived: sum of 2 quarters · filed 2026-07-28 | $1.18M derived: sum of 3 quarters · filed 2026-07-28 | $13.56M 10-K · filed 2026-07-28 | |||
| 2025-02-28 | -$2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | -$6.81M derived: sum of 2 quarters · filed 2026-04-01 | $5.58M 10-Q · filed 2026-04-01 | $16.53M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-11-30 | -$4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $8.13M 10-Q · filed 2026-01-08 | $19.08M derived: sum of 3 quarters · filed 2026-07-28 | $32.37M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-08-31 | $12.38M 10-Q · filed 2025-10-09 | $23.33M derived: sum of 2 quarters · filed 2026-07-28 | $36.63M derived: sum of 3 quarters · filed 2026-07-28 | $31.61M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-05-31 | $10.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $24.25M derived: sum of 2 quarters · filed 2026-07-28 | $19.23M derived: sum of 3 quarters · filed 2026-07-28 | $15.58M 10-K · filed 2026-07-28 | |||
| 2024-02-29 | $13.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $8.28M derived: sum of 2 quarters · filed 2025-04-08 | $4.63M 10-Q · filed 2025-04-08 | $5.75M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-11-30 | -$5.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | -$8.67M 10-Q · filed 2025-01-10 | -$7.54M derived: sum of 3 quarters · filed 2025-07-29 | $9.31M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-08-31 | -$3.65M 10-Q · filed 2024-10-10 | -$2.52M derived: sum of 2 quarters · filed 2025-07-29 | $14.33M derived: sum of 3 quarters · filed 2025-07-29 | $9.05M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-05-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $17.98M derived: sum of 2 quarters · filed 2025-07-29 | $12.70M derived: sum of 3 quarters · filed 2025-07-29 | $12.93M 10-K · filed 2025-07-29 | |||
| 2023-02-28 | $16.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $11.58M derived: sum of 2 quarters · filed 2024-04-09 | $11.81M 10-Q · filed 2024-04-09 | $41.05M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-11-30 | -$5.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | -$5.05M 10-Q · filed 2024-01-09 | $24.19M derived: sum of 3 quarters · filed 2024-10-10 | $44.11M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-08-31 | $232.00K 10-Q · filed 2024-10-10 | $29.47M derived: sum of 2 quarters · filed 2024-10-10 | $49.39M derived: sum of 3 quarters · filed 2024-10-10 | $50.90M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-05-31 | $29.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $49.16M derived: sum of 2 quarters · filed 2024-07-30 | $50.67M derived: sum of 3 quarters · filed 2024-07-30 | $45.75M 10-K · filed 2024-07-30 | -$45.75M 10-K · filed 2022-07-28 | ||
| 2022-02-28 | $19.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | $21.43M derived: sum of 2 quarters · filed 2023-04-10 | $16.51M 10-Q · filed 2023-04-10 | $55.89M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-11-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | -$3.41M 10-Q · filed 2023-01-09 | $35.97M derived: sum of 3 quarters · filed 2023-07-26 | ||||
| 2021-08-31 | -$4.92M 10-Q · filed 2022-10-07 | $34.45M derived: sum of 2 quarters · filed 2023-07-26 | |||||
| 2021-05-31 | $39.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $55.20M 10-K · filed 2023-07-26 | -$35.29M 10-K · filed 2021-07-28 | ||||
| 2021-03-31 | $4.89M 10-Q · filed 2021-05-10 | ||||||
| 2021-02-28 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $15.83M 10-Q · filed 2022-04-06 | |||||
| 2020-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $30.07M 10-K · filed 2021-02-19 | |||||
| 2020-11-30 | $19.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $18.35M 10-Q · filed 2022-01-10 | |||||
| 2020-09-30 | $4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $25.48M 10-Q · filed 2020-11-09 | |||||
| 2020-08-31 | -$1.23M 10-Q · filed 2021-10-07 | ||||||
| 2020-06-30 | $9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $20.89M 10-Q · filed 2020-08-10 | $49.78M derived: sum of 3 quarters · filed 2021-05-10 | $84.81M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2020-05-31 | -$89.66M 10-K · filed 2022-07-28 | ||||||
| 2020-03-31 | $11.59M 10-Q · filed 2021-05-10 | $40.48M derived: sum of 2 quarters · filed 2021-05-10 | $75.51M derived: sum of 3 quarters · filed 2021-05-10 | $100.93M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $28.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $63.91M derived: sum of 2 quarters · filed 2021-02-19 | $89.34M derived: sum of 3 quarters · filed 2021-02-19 | $102.64M 10-K · filed 2021-02-19 | |||
| 2019-09-30 | $35.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $60.45M derived: sum of 2 quarters · filed 2020-11-09 | $73.76M 10-Q · filed 2020-11-09 | $75.23M derived: sum of 4 quarters · filed 2021-02-19 | |||
| 2019-06-30 | $25.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $38.73M 10-Q · filed 2020-08-10 | $40.20M derived: sum of 3 quarters · filed 2021-02-19 | $47.53M derived: sum of 4 quarters · filed 2021-02-19 | |||
| 2019-05-31 | -$26.07M 10-K · filed 2021-07-28 | ||||||
| 2019-03-31 | $13.31M 10-Q · filed 2020-05-11 | $12.98M 10-Q · filed 2019-05-15 | $14.78M derived: sum of 2 quarters · filed 2021-02-19 | $22.11M derived: sum of 3 quarters · filed 2021-02-19 | $21.27M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2018-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $8.80M derived: sum of 2 quarters · filed 2021-02-19 | $7.97M derived: sum of 3 quarters · filed 2021-02-19 | $9.23M 10-K · filed 2021-02-19 | |||
| 2018-09-30 | $7.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $6.50M derived: sum of 2 quarters · filed 2019-11-13 | $7.75M 10-Q · filed 2019-11-13 | $8.97M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | -$831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $428.00K 10-Q · filed 2019-08-13 | -$48.00K 10-Q · filed 2018-08-29 | $1.64M derived: sum of 3 quarters · filed 2020-03-02 | $2.67M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $1.26M 10-Q · filed 2019-05-15 | $2.47M derived: sum of 2 quarters · filed 2020-03-02 | $3.50M derived: sum of 3 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.24M derived: sum of 2 quarters · filed 2020-03-02 | $3.29M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $2.08M 10-Q · filed 2018-11-14 | |||||
| 2017-06-30 | $1.05M 10-Q · filed 2018-08-29 | ||||||
| 2016-12-31 | -$693.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |